The immune cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has
attracted rapidly evolving attention as a cancer treatment modality because of its …

Colorectal cancer is one of the most common cancers among the elderly, which is also seen
in the forms of hereditary syndromes occurring in younger individuals. Numerous studies …

Resistance to tumor‐necrosis‐factor‐related apoptosis‐inducing ligand (TRAIL) of cancer
cell remains a key obstacle for clinical cancer therapies. To overcome TRAIL resistance, this …

Cancer is among the leading causes of mortality worldwide. Current cancer therapies are
associated with serious side effects, which further damage patients' health. Therefore, the …

Background: An increasing number of studies have shown that natural products have anti-
tumor effects, and it has become a hotspot in cancer research. However, few bibliometric …

Breast cancer therapy using anticancer bioactive compounds derived from natural products
as adjuvant treatment has gained recognition due to expensive and toxic conventional …

In triple-negative breast cancer (TNBC), the tumor microenvironment is associated with
increased proliferation, suppressing apoptotic mechanisms, an altered immune response …

Bailly C. 2021. Anticancer mechanism of artonin E and related prenylated flavonoids from
the medicinal plant Artocarpus elasticus. Asian J Nat Prod Biochem 19: 45-57. Plants of the …

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is selectively lethal to
cancer cells and harmless to normal cells, making it a potential agent for cancer therapy …

Apoptosis, or programmed cell death, is a fundamental biological process essential for
maintaining tissue homeostasis. Dysregulation of apoptosis is implicated in a variety of …